PharmaShots | Incisive News in 3 Shots

Subscribe Now

fixed-dose combination

Roche's Phesgo (fixed-dose combination of Perjeta and Herceptin) Receives the US FDA's Approval for Early and Metastatic HER2-Positive Breast Cancer

Roche's Phesgo (fixed-dose combination of Perjeta and Herceptin) Receives the US FDA's Approval for Early and Metastatic HER2-Posi...

June 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us